SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Webull Corp. engages in the provision of financial services. It offers trading, wealth management product distribution, market data and information, user community, and investor education. The company was founded by An Quan Wang in 2016 and is headquartered in St. Petersburg, FL.

Webull Corp. - Ordinary Shares - Class A

Webull Corp

Webull ($BULL) is trending downwards, with the community actively discussing a potential share dilution and insider lockup expiration as possible catalysts. Concerns about management and valuation are prevalent, with some traders anticipating further declines while others see a buying opportunity amid oversold conditions. Despite the bearish sentiment, some community members express long-term bullishness, comparing it to similar fintech plays.

AST Spacemobile, Inc. engages in building a broadband cellular network in space to operate directly with standard, unmodified mobile devices based on an extensive IP and patent portfolio. It focuses on providing mobile broadband services with global coverage to all end-users, without the need to purchase special equipment. The company was founded by Abel Avellan on May 31, 2017 and is headquartered in Midland, TX.

AST SpaceMobile Inc - Ordinary Shares - Class A

AST SpaceMobile Inc

AST SpaceMobile is trending due to a definitive commercial agreement with Verizon to provide space-based cellular broadband, planned to start in 2026, which the community sees as a major validation of the technology. Community members are actively discussing the potential for a short squeeze and the long-term implications of the deal, while some express concern over a recent stock offering. The broader context involves the company's efforts to provide direct-to-device connectivity via satellite and compete with other players in the satellite communication space.

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending amid news of an offtake agreement with REalloys, sparking bullish sentiment among investors who anticipate potential government involvement and a surge in stock value. The community is actively discussing the implications of this deal, potential short squeezes, and the company's strategic positioning in the rare earth element supply chain. Despite conflicting reports regarding government stakes, optimism persists due to the increasing demand for critical minerals and CRML's valuable assets.

POET Technologies, Inc. engages in the designing, developing, manufacturing and sale of opto-electronic solutions for the sensing, data communications and telecommunications markets. It developed POET Optical Interposer platform, which allows the integration of electronic and photonic devices into a single multi-chip module. The company was founded on November 14, 1985 and is headquartered in Toronto, Canada.

POET Technologies Inc

POET Technologies is trending following a $75 million investment to accelerate growth in AI connectivity solutions, leading to community speculation about the investor's identity and strategic intentions. The community is focused on the potential impact of this investment on POET's market position, particularly in chip-to-chip communication and potential M&A activity within the AI hardware landscape. Key discussion points revolve around the company's partnerships and its capacity to alleviate bottlenecks in AI data centers.

Universe Pharmaceuticals, Inc. is a pharmaceutical company. The firm is focused on the manufacturing, marketing, sales, and distribution of traditional Chinese medicine derivative products. It also sells biomedical drugs, medical instruments, traditional Chinese medicine Pieces, and dietary supplements manufactured by third-party pharmaceutical companies. The company was founded on March 2, 1998 and is headquartered in Ji'an, China.

Universe Pharmaceuticals INC

Universe Pharmaceuticals ($UPC) is trending due to discussions surrounding its low float and substantial cash reserves, leading to speculation about potential strategic moves. The community is drawing comparisons to other recent low-float runners, anticipating a similar breakout. Traders are closely monitoring for news catalysts that could trigger a significant price increase.

TransCode Therapeutics, Inc. engages in the development and commercializing of diagnostics and therapeutics for the detection and treatment of cancer. The company was founded by Robert Michael Dudley, Zdravka Medarova, and Anna Moore in January 2016 and is headquartered in Boston, MA.

TransCode Therapeutics Inc

RNAZ is trending due to its announcement of acquiring Polynoma and securing $25 million in financing, with the community actively discussing the potential impact of these developments. While some express optimism about the company's future and potential short squeeze opportunities given the low float, others are wary, pointing to past reverse splits and potential dilution. Discussions also revolve around the company's microRNA-based pipeline and upcoming Phase 2 trials.

Rocket Lab Corp. engages in the development of rocket launch and control systems for the space and defense industries. It operates through the Launch Services and Space Systems segments. The Launch Services segment provides launch services to customers on a dedicated mission or ride share basis. The Space Systems segment consists of spacecraft engineering and design services, spacecraft components, spacecraft manufacturing, and on-orbit mission operations. The company is headquartered in Long Beach, CA.

Rocket Lab Corp.

Rocket Lab USA Inc

Rocket Lab is trending amid renewed investor optimism, fueled by multi-launch contract news and overall excitement around the company's growth trajectory. Community members are actively discussing Neutron development progress and potential government contracts, while some caution against overvaluation given recent insider selling. The stock's strong performance is attracting both bullish sentiment and concerns about an upcoming pullback.

AlphaTON Capital Corp. is a biotechnology company, which engages in the research and development of immuno-oncology therapies for patients with cancer. Its portfolio includes first-in-class invariant natural killer T cell (iNKT) small molecule engagers and best-in-class adenosine antagonists. The company was founded by Gregory H. Bailey and James Mellon in 1973 and is headquartered in Road Town, British Virgin Islands.

AlphaTON Capital Corp.

AlphaTON Capital Corp is trending as community members discuss its low float and potential squeeze, particularly after news of the company tokenizing its mesothelioma treatment program. Traders are actively watching key price levels for breakouts, drawing comparisons to other recent low-float runners. The company's move to merge digital assets with oncology innovation is also sparking interest.

Sarepta Therapeutics, Inc. is a commercial-stage biopharmaceutical company, which is engaged in the discovery and development of therapeutics for the treatment of rare diseases. The company was founded on July 22, 1980, and is headquartered in Cambridge, MA.

Sarepta Therapeutics Inc

Sarepta Therapeutics is trending amid community discussions about a potential short squeeze and optimism surrounding upcoming clinical data presentations. Investors are also focused on analyst ratings and the company's strategic restructuring, contributing to renewed confidence in the stock. Some speculate positive news or a possible buyout could drive further gains.

Xenetic Biosciences, Inc. is a biopharmaceutical company engaged in the advancement of cell-based therapeutics to target the B-cell receptor on the surface of an individual patient’s malignant tumor cells. Its product pipeline includes XCart Platform and Polyxen. The company was founded on August 9, 2011 and is headquartered in Framingham, MA.

Xenetic Biosciences Inc

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Aston Martin shares slid more than 3% in London on Wednesday after the British luxury carmaker cut its 2025 profit outlook, blaming "evolving and disruptive" U.S. auto tariffs.Under a U.S.-UK trade deal implemented in May, the first 100,000 UK car imports are subject to a 10% tariff, while any shipments exceeding that threshold are subject to a 27.5% duty. Aston Martin stated that the quota system is hindering its ability to forecast results and could impact margins into 2026."We continue to actively engage the UK government to urge them to improve the quota mechanism to ensure fair access for the whole UK car industry to the 10% rate on an ongoing basis," CEO Adrian Hallmark said in a statement.The company now expects its gross margin this year to be broadly in line with last year's 37%, which is below its prior target of 40%. Adjusted earnings before interest and tax (EBIT) may no longer turn positive in 2025, instead moving toward breakeven.For the latest quarter, Aston Martin posted an adjusted operating loss of £57 million&nbsp;($76.16 million) versus a £42.7 million loss a year ago. Revenue fell 34% to £220.5 million, below the consensus of £270 million. Wholesale volumes dropped 8% to 972 units, while retail deliveries outpaced wholesales by over 40%.The broader UK auto industry is also reeling, with output&nbsp;<a target="_blank" rel="noopener noreferrer nofollow" href="https://www.cnbc.com/2025/06/27/trump-tariffs-uk-car-and-vehicle-output-falls-to-76-year-low-in-may.html#:~:text=The%20U.K.'s%20new%20car,level%20since%201949%20in%20May.">reportedly</a> at its lowest level since 1949, as exports have paused amid Trump's tariffs.&nbsp;Aston Martin’s London-listed shares are down 26% year-to-date, while its over-the-counter stock in the U.S. has fallen nearly 14%.On Stocktwits, retail sentiment toward Aston Martin remains 'bearish' amid 'high' message volume late Tuesday.(£1 = $1.34)For updates and corrections, email newsroom[at]stocktwits[dot]com.Read Next:&nbsp;<a href="https://stocktwits.com/news-articles/markets/equity/li-auto-just-launched-its-first-electric-suv-here-s-why-investors-are-already-backing-off/choQ86IR5yy">Li Auto Just Launched Its First Electric SUV: Here’s Why Investors Are Already Backing Off</a>

An Aston Martin Vantage is displayed in the Mayfair showroom on Park Lane on January 09, 2025 in London, England. (Photo by John Keeble/Getty Images)

Aston Martin Wants UK To Tweak Trump Trade Deal After Cutting 2025 Targets On 'Disruptive' Auto Tariffs

Adjusted earnings before interest and tax (EBIT) may no longer turn positive in 2025, the company said, instead moving toward breakeven.

Equity

Aston Martin Lagonda Global Holdings Plc engages in the business of designing, creating, and exporting cars. Its current models include the Vantage, dB12, Vanquish, DBX707, Valhalla, Valkyrie, Valour, Valiant amd AMR25 F1. The company was founded by Robert Bamford and Lionel Martin on January 15, 1913 and is headquartered in Warwick, the United Kingdom.

Aston Martin Lagonda Global Holdings Plc

Will JP Morgan Chase ($JPM) beat quarterly earnings?  
 
*Powered by Polymarket

Stocktwits

JPMorgan Chase & Co

) beat quarterly earnings?  
 
*Powered by Polymarket

Current Price	$0.97
Prev Close	$1.02
Open	$1.00
Dividend Yield	0.00%
50-Day Moving Average	$1.02
Beta	0.51
Avg. Volume	3,863.33
PE Ratio	-2.57

52-Week High	$1.74
52-Week Low	$0.75
Market Capitalization	$713.79M
EPS (Annual)	-$0.4966
Price to Book	1.07
Revenue Per Employee	$673,295.71
Enterprise Value/EBITDA	N/A

AMGDF Aston Martin Lagonda Global Holdings Plc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest AMGDF News